In contrast, two N-terminal domains of EZH2 interacts directly with β-catenin and estrogen receptor alpha (ERα), and thus links the Wnt and estrogen signaling pathways, leading to gene transactivation and cell cycle progression in breast cancer cells [22]. This evidence concerns the gene ESR1 and breast carcinoma.